By Michael Erman (Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for...
Month: October 2023
NEW YORK (Reuters) -The violence in Israel that erupted this weekend is prompting a move into safe-haven...
(Reuters) – Pharmacy employees at some U.S. Walgreens stores, including pharmacists, technicians and support staff, plan a...
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – Americans have started rolling up their sleeves...
(Reuters) – Federal Reserve Governor Michelle Bowman on Saturday repeated her view that inflation continues to be...
By Stephen Nellis and Max A. Cherney (Reuters) – In a new front in the U.S.-China tech...
By Joey Roulette WASHINGTON (Reuters) -Amazon’s first pair of prototype satellites for its planned Kuiper internet network...
By Sachin Ravikumar LONDON (Reuters) -Snapchat may have failed to properly assess privacy risks to children from...
(Reuters) – Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after...
By Michael Martina and Humeyra Pamuk WASHINGTON (Reuters) -Early in the Biden administration, U.S. Secretary of State...